PUBLICATION

Assessing CaMPARI as new approach methodology for evaluating neurotoxicity

Authors
Biechele-Speziale, D., Camarillo, M., Martin, N.R., Biechele-Speziale, J., Lein, P.J., Plavicki, J.S.
ID
ZDB-PUB-230528-65
Date
2023
Source
Neurotoxicology   97: 109-119 (Journal)
Registered Authors
Martin, Nathan, Plavicki, Jessica
Keywords
CaMPARI, behavior, neurotoxicity, zebrafish
MeSH Terms
  • Animals
  • Brain
  • Calcium*/metabolism
  • Humans
  • Mammals
  • Neurons
  • Neurotoxicity Syndromes*/etiology
  • Neurotoxicity Syndromes*/metabolism
  • Swimming
  • Zebrafish
PubMed
37244562 Full text @ Neurotoxicology
Abstract
Developmental exposure to environmental toxicants has been linked to the onset of neurological disorders and diseases. Despite substantial advances in the field of neurotoxicology, there remain significant knowledge gaps in our understanding of cellular targets and molecular mechanisms that mediate the neurotoxicological endpoints associated with exposure to both legacy contaminants and emerging contaminants of concern. Zebrafish are a powerful neurotoxicological model given their high degree sequence conservation with humans and the similarities they share with mammals in micro- and macro-level brain structures. Many zebrafish studies have effectively utilized behavioral assays to predict the neurotoxic potential of different compounds, but behavioral phenotypes are rarely able to predict the brain structures, cell types, or mechanisms affected by chemical exposures. Calcium-modulated photoactivatable ratiometric integrator (CaMPARI), a recently developed genetically-encoded calcium indicator, undergoes a permanent green to red switch in the presence of elevated intracellular Ca2+ concentrations and 405-nm light, which allows for a "snapshot" of brain activity in freely-swimming larvae. To determine whether behavioral results are predictive of patterns of neuronal activity, we assessed the effects of three common neurotoxicants, ethanol, 2,2',3,5',6-pentachlorobiphenyl (PCB 95), and monoethylhexyl phthalate (MEHP), on both brain activity and behavior by combining the behavioral light/dark assay with CaMPARI imaging. We demonstrate that brain activity profiles and behavioral phenotypes are not always concordant and, therefore, behavior alone is not sufficient to understand how toxicant exposure affects neural development and network dynamics. We conclude that pairing behavioral assays with functional neuroimaging tools such as CaMPARI provides a more comprehensive understanding of the neurotoxic endpoints of compounds while still offering a relatively high throughput approach to toxicity testing.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping